OPTIC primary analysis: A dose-optimization study of 3 starting doses of ponatinib (PON) Meeting Abstract


Authors: Cortes, J. E.; Apperley, J.; Lomaia, E.; Moiraghi, B.; Sutton, M. U.; Pavlovsky, C.; Chuah, C.; Sacha, T.; Lipton, J. H.; Schiffer, C.; McCloskey, J. K.; Hochhaus, A.; Rousselot, P. H.; Rosti, G.; De Lavallade, H.; Mauro, M. J.; Hall, T.; Lu, V.; Srivastava, S.; Deininger, M. W.
Abstract Title: OPTIC primary analysis: A dose-optimization study of 3 starting doses of ponatinib (PON)
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120604049
DOI: 10.1200/JCO.2021.39.15_suppl.7000
PROVIDER: wos
Notes: Meeting Abstract: 7000 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael John Mauro
    267 Mauro